Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that indoximod, its investigational drug candidate, was granted orphan-drug designation by the U.
Investors are racing to buy TrovaGene Inc (NASDAQ:TROV) shares after the U.S.